Clinical Report: Effects of Subtotal Pancreatectomy on Patients with Congenital Hyperinsulinism
Overview
This study examines the long-term impacts of subtotal pancreatectomy on patients with congenital hyperinsulinism (HI) and their caregivers. Findings indicate significant post-surgery challenges, including diabetes and pancreatic insufficiency.
Background
Congenital hyperinsulinism is a rare but serious condition leading to recurrent hypoglycemia in infants. Subtotal pancreatectomy is a treatment option for diffuse HI when medical therapies fail, yet the long-term consequences of this surgery are not well understood.
Data Highlights
Outcome
Percentage
Diabetes
44%
Pancreatic Insufficiency
41%
Ongoing Medication Use for Hypoglycemia
24%
Normal Glucose Status at Discharge
9%
Key Findings
71% of participants underwent subtotal pancreatectomy before two months of age.
At follow-up, 44% reported diabetes and 41% reported pancreatic insufficiency.
24% of participants continued to use medication for hypoglycemia post-surgery.
Continuous glucose monitoring indicated suboptimal time in range, regardless of diabetes status.
Caregivers reported significant stress during hospitalization and post-discharge periods.
Children perceived less burden from their condition compared to their caregivers.
Clinical Implications
Healthcare providers should be aware of the potential long-term complications following subtotal pancreatectomy for congenital hyperinsulinism, including diabetes and pancreatic insufficiency.
Conclusion
Subtotal pancreatectomy for diffuse congenital hyperinsulinism can lead to significant long-term health challenges.
Acidic gum beat sugar-free at cranking out nitric oxide from beetroot juice — exactly backward from what test-tube studies predicted. Also this week: a sleep gene that ignores amyloid, and jackfruit sap moonlighting as a bone-building drug delivery system.
